These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 3279384)

  • 21. Pharmacokinetics of cefodizime following single doses of 0.5, 1.0, 2.0, and 3.0 grams administered intravenously to healthy volunteers.
    Lenfant B; Namour F; Logeais C; Coussediere D; Rivault O; Bryskier A; Surjus A
    Antimicrob Agents Chemother; 1995 Sep; 39(9):2037-41. PubMed ID: 8540712
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetic profile of cefotaxime in goats.
    Atef M; Ramadan A; Afifi NA; Youssef SA
    Res Vet Sci; 1990 Jul; 49(1):34-8. PubMed ID: 2382053
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of cefotaxime and desacetylcefotaxime in the young.
    Kearns GL; Young RA
    Diagn Microbiol Infect Dis; 1995; 22(1-2):97-104. PubMed ID: 7587057
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cefotaxime pharmacokinetics in Arabian camel (Camelus dromedarius) calves after single intravenous injection.
    Altayban A; Kandeel M; Tahoun A; Al-Nazawi M
    Trop Anim Health Prod; 2020 Mar; 52(2):887-891. PubMed ID: 31696417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of cefotaxime in patients after liver transplantation.
    Kuse E; Vogt P; Rosenkranz B
    Infection; 1990; 18(5):268-72. PubMed ID: 2276819
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical pharmacokinetics of cefotaxime in patients with normal and reduced renal function.
    Doluisio JT
    Rev Infect Dis; 1982; 4 Suppl():S333-45. PubMed ID: 6294782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of cefotaxime in the postpartum patient.
    Gonik B; Cotton DB; Feldman S; Cleary TG; Pickering LK
    Am J Perinatol; 1985 Apr; 2(2):114-7. PubMed ID: 4096751
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pharmacokinetics of cefmenoxime in the aged subject (60 to 90 years of age) after an intravenous injection of 1 g].
    Veyssier P; Bryskier A; Modai J; Boquet A; Fourtillan JB
    Pathol Biol (Paris); 1986 Dec; 34(10):1081-3. PubMed ID: 3547264
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pharmacokinetics of cefotaxime during late pregnancy].
    Voigt R; Schröder S; Bierwisch I; Michels W
    Z Geburtshilfe Perinatol; 1989; 193(5):230-2. PubMed ID: 2683434
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The relation between type of renal disease and renal drug clearance in children.
    Paap CM; Nahata MC
    Eur J Clin Pharmacol; 1993; 44(2):195-7. PubMed ID: 8453966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of cefotaxime in healthy volunteers and patients.
    Patel KB; Nicolau DP; Nightingale CH; Quintiliani R
    Diagn Microbiol Infect Dis; 1995; 22(1-2):49-55. PubMed ID: 7587050
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of hepatic failure upon the pharmacokinetics of cefixime].
    Singlas E; Lebrec D; Gaudin C; Montay G; Roche G; Taburet AM
    Presse Med; 1989 Oct; 18(32):1587-8. PubMed ID: 2530538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigation of the biliary clearances of cefotaxime and desacetylcefotaxime by an original procedure in cholecystectomised patients.
    Jehl F; Peter JD; Picard A; Dupeyron JP; Marescaux J; Sibilly A; Monteil H
    Infection; 1987; 15(6):450-4. PubMed ID: 3436677
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of cefotaxime and its desacetyl metabolite in plasma and in cerebrospinal fluid.
    Beyssac E; Cardot JM; Colnet G; Sirot J; Aiache JM
    Eur J Drug Metab Pharmacokinet; 1987; 12(2):91-102. PubMed ID: 3691581
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of cefotaxime and desacetylcefotaxime in the newborn.
    Aujard Y; Brion F; Jacqz-Aigrain E; Kasse MC; Chretien P; Criqui C; Mathieu H
    Diagn Microbiol Infect Dis; 1989; 12(1):87-91. PubMed ID: 2653716
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Assay of cefotaxime and desacetylcefotaxime in plasma and urine by high performance liquid chromatography].
    Demotes-Mainard F; Vinçon G; Bouchet JL; Jarry C; Albin H
    Ann Biol Clin (Paris); 1984; 42(4):301-5. PubMed ID: 6093635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Single-dose pharmacokinetics of cefodizime in critically ill elderly patients.
    Meyer B; Traunmueller F; Bojic A; Locker G; Schmid R; Winkler S; Thalhammer F
    Int J Antimicrob Agents; 2006 Apr; 27(4):335-8. PubMed ID: 16563704
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pharmacokinetics of cefotaxime in cirrhotic patients with or without ascites].
    Vincent P; Colombel JF; Husson MO; Izard D; Paris JC; Leclerc H
    Presse Med; 1988 Dec; 17(44):2331-4. PubMed ID: 2974968
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Subcutaneous pharmacokinetics and dosage regimen of cefotaxime in buffalo calves (Bubalus bubalis).
    Sharma SK; Srivastava AK
    J Vet Sci; 2006 Jun; 7(2):119-22. PubMed ID: 16645334
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of cefodizime: a review of the data on file.
    Barré J
    J Antimicrob Chemother; 1990 Nov; 26 Suppl C():95-101. PubMed ID: 2074258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.